Levels  	Levels  	 NNS	O
of  	of  	 IN	O
Beclin  	Beclin  	 NNP	B-NP
1  	1  	 CD	O
and  	and  	 CC	O
LC3  	LC3  	 CD	B-NP
in  	in  	 IN	O
peripheral  	peripheral  	 JJ	B-NP
blood  	blood  	 NN	I-NP
mononuclear  	mononuclear  	 NN	I-NP
cells  	cells  	 NNS	I-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
multiple  	multiple  	 JJ	O
sclerosis  	sclerosis  	 NN	O
and  	and  	 CC	O
neuromyelitis  	neuromyelitis  	 JJ	B-NP
optica  	optica  	 NN	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
significance  	significance  	 NN	B-NP
To  	To  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
expression  	expression  	 NN	O
and  	and  	 CC	O
significance  	significance  	 NN	B-NP
of  	of  	 IN	I-NP
Beclin  	Beclin  	 NNP	I-NP
1  	1  	 CD	O
and  	and  	 CC	O
LC3  	LC3  	 CD	B-NP
in  	in  	 IN	O
peripheral  	peripheral  	 JJ	B-NP
blood  	blood  	 NN	I-NP
mononuclear  	mononuclear  	 NN	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
PBMCs 	PBMCs 	 NNP	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
multiple  	multiple  	 JJ	B-NP
sclerosis  	sclerosis  	 NNS	I-NP
( 	( 	 -LRB-	O
MS 	MS 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
neuromyelitis  	neuromyelitis  	 JJ	B-NP
optica  	optica  	 NNS	I-NP
( 	( 	 -LRB-	O
NMO 	NMO 	 NNP	B-NP
)  	)  	 -RRB-	O
before  	before  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
treatment  	treatment  	 NN	O
during  	during  	 IN	O
acute  	acute  	 JJ	O
and  	and  	 CC	O
recurrent  	recurrent  	 JJ	O
acute  	acute  	 JJ	O
phases 	phases 	 NNS	O
.  	.  	 .	O
All  	All  	 DT	O
outpatients 	outpatients 	 NN	O
,  	,  	 ,	O
inpatients  	inpatients  	 NN	B-NP
and  	and  	 CC	O
healthy  	healthy  	 JJ	O
controls  	controls  	 NNS	O
were  	were  	 VBD	O
recruited  	recruited  	 VBN	O
from  	from  	 IN	O
our  	our  	 PRP$	O
hospital  	hospital  	 NN	O
from  	from  	 IN	O
October  	October  	 NNP	O
2012  	2012  	 CD	O
to  	to  	 TO	O
April  	April  	 NNP	O
2014 	2014 	 CD	O
.  	.  	 .	O
During  	During  	 IN	O
acute  	acute  	 JJ	O
phase 	phase 	 NN	O
,  	,  	 ,	O
PBMCs  	PBMCs  	 JJ	O
from  	from  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
multiple  	multiple  	 JJ	B-NP
sclerosis  	sclerosis  	 NNS	I-NP
( 	( 	 -LRB-	O
MS 	MS 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
neuromyelitis  	neuromyelitis  	 JJ	B-NP
optica  	optica  	 NNS	I-NP
( 	( 	 -LRB-	O
NMO 	NMO 	 NNP	B-NP
) 	) 	 -RRB-	O
( 	( 	 -LRB-	O
pre  	pre  	 NN	B-NP
and  	and  	 CC	O
post-treatment 	post-treatment 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
immediately  	immediately  	 RB	O
isolated  	isolated  	 VBN	O
by  	by  	 IN	O
Ficoll-Hypaque  	Ficoll-Hypaque  	 JJ	B-NP
density  	density  	 JJ	I-NP
gradient  	gradient  	 JJ	I-NP
centrifugation 	centrifugation 	 NN	I-NP
.  	.  	 .	O
And  	And  	 CC	O
the  	the  	 DT	O
expressions  	expressions  	 NNS	O
of  	of  	 IN	O
Beclin  	Beclin  	 NNP	B-NP
1  	1  	 CD	O
and  	and  	 CC	O
LC3  	LC3  	 NNP	B-NP
were  	were  	 VBD	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
Western  	Western  	 JJ	O
blot 	blot 	 NN	O
.  	.  	 .	O
And  	And  	 CC	O
relapsing-remitting  	relapsing-remitting  	 NNP	B-NP
MS  	MS  	 NNP	I-NP
( 	( 	 -LRB-	O
RRMS 	RRMS 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
relapsing  	relapsing  	 JJ	B-NP
NMO  	NMO  	 NNP	I-NP
( 	( 	 -LRB-	O
RNMO 	RNMO 	 NNP	B-NP
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
followed  	followed  	 VBN	O
up  	up  	 RP	O
and  	and  	 CC	O
the  	the  	 DT	O
expressions  	expressions  	 NNS	O
of  	of  	 IN	O
Beclin  	Beclin  	 NNP	B-NP
1  	1  	 CD	O
and  	and  	 CC	O
LC3  	LC3  	 CD	B-NP
proteins  	proteins  	 NNS	I-NP
compared  	compared  	 VBN	O
during  	during  	 IN	O
two  	two  	 CD	O
acute  	acute  	 JJ	O
phases 	phases 	 NNS	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
with  	with  	 IN	O
normal  	normal  	 JJ	B-NP
controls 	controls 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
Beclin  	Beclin  	 NNP	B-NP
1  	1  	 CD	O
in  	in  	 IN	O
PBMCs  	PBMCs  	 JJ	O
from  	from  	 IN	O
acute  	acute  	 JJ	O
phase  	phase  	 NN	O
of  	of  	 IN	O
MS  	MS  	 NNP	B-NP
and  	and  	 CC	O
NMO  	NMO  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
decreased  	decreased  	 VBD	O
while  	while  	 IN	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
LC3  	LC3  	 NNP	B-NP
increased 	increased 	 VBD	O
.  	.  	 .	O
During  	During  	 IN	O
acute  	acute  	 JJ	O
phase 	phase 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
Beclin  	Beclin  	 NNP	B-NP
1  	1  	 CD	O
significantly  	significantly  	 RB	O
increased  	increased  	 VBN	O
after  	after  	 IN	O
treatment  	treatment  	 NN	O
in  	in  	 IN	O
MS  	MS  	 NNP	B-NP
and  	and  	 CC	O
NMO  	NMO  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
pre-treatment 	pre-treatment 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
LC3  	LC3  	 NNP	B-NP
significantly  	significantly  	 RB	O
decreased 	decreased 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
Beclin1  	Beclin1  	 NNP	B-NP
obviously  	obviously  	 RB	O
decreased  	decreased  	 VBN	O
in  	in  	 IN	O
RRMS  	RRMS  	 NNP	B-NP
and  	and  	 CC	O
recurrent  	recurrent  	 JJ	O
RNMO  	RNMO  	 NNS	B-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
previous  	previous  	 JJ	O
period 	period 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
LC3  	LC3  	 NNP	B-NP
significantly  	significantly  	 RB	O
increased 	increased 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
autophagy  	autophagy  	 JJ	B-NP
level  	level  	 NN	I-NP
increases  	increases  	 NNS	I-NP
in  	in  	 IN	O
PBMC  	PBMC  	 NNP	B-NP
from  	from  	 IN	O
MS  	MS  	 NNP	B-NP
and  	and  	 CC	O
NMO  	NMO  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
during  	during  	 IN	O
acute  	acute  	 JJ	O
phase 	phase 	 NN	O
.  	.  	 .	O
However  	However  	 RB	O
it  	it  	 PRP	O
decreases  	decreases  	 VBZ	O
after  	after  	 IN	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
autophagy  	autophagy  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
significantly  	significantly  	 RB	O
increase  	increase  	 VB	O
in  	in  	 IN	O
RRMS  	RRMS  	 NNP	B-NP
and  	and  	 CC	O
RNMO 	RNMO 	 NNP	B-NP
.  	.  	 .	O
And  	And  	 CC	O
enhanced  	enhanced  	 JJ	O
autophagy  	autophagy  	 NN	B-NP
may  	may  	 MD	O
play  	play  	 VB	O
its  	its  	 PRP$	O
role  	role  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
MS  	MS  	 NNP	I-NP
and  	and  	 CC	O
NMO 	NMO 	 NNP	B-NP
.  	.  	 .	O
